Zonisamide in managing impulse control disorders in Parkinson's disease

Journal of Neurology

Volumn 257, Issue 10, 2010, Pages 1682-1685

  Bermejo, Pedro Emilio ^a   Ruiz Huete, Cristina ^b   Anciones, Buenaventura ^b  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b Hospital Sanitas La Zarzuela   (Spain)

Author keywords

Anticonvulsant; Impulse control disorders; Parkinson's disease; Zonisamide

Indexed keywords

CARBIDOPA; LEVODOPA; RASAGILINE; ROPINIROLE; ZONISAMIDE; ANTIOXIDANT; ISOXAZOLE DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COMPULSION; CONCENTRATION LOSS; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EATING DISORDER; FATIGUE; FEMALE; HUMAN; HYPERSEXUALITY; IMPULSE CONTROL DISORDER; MALE; PARESTHESIA; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; UNIFIED PARKINSON DISEASE RATING SCALE; MIDDLE AGED; RETROSPECTIVE STUDY;

AGED; ANTIOXIDANTS; FEMALE; HUMANS; IMPULSE CONTROL DISORDERS; ISOXAZOLES; MALE; MIDDLE AGED; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES;

EID: 79952200580     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5603-7     Document Type: Article

References (28)

1. Evans AH, Strafella AP, Weintraub D et al (2009) Impulsive and compulsive behaviors in Parkinson's disease. Mov Disord 24:1561-1570
2. Ceravolo R, Frosini D, Rossi C et al (2009) Prevalence of impulse control disorders in Parkinson's disease. Neurol Sci 30(suppl):456
3. Bermejo PE (2008) Topiramate in managing impulse control disorders in Parkinson's disease. Parkinsonism Relat Disord 14:448-449
4. Baulac M, Leppik IE (2007) Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures. Epilepsy Res 75:75-83
5. Bermejo PE, Dorado R (2009) Zonisamide for migraine prophylaxis in patients refractory to topiramate. Clin Neuropharmacol 32:103-106
6. Atli A, Dogra S (2005) Zonisamide in the treatment of painful diabetic neuropathy: a randomized, double-blind, placebo-controlled pilot study. Pain Med 6:225-234
7. Bermejo PE, Ruiz-Huete C, Dorado R et al (2008) Zonisamida en el temblor esencial refractario. Rev Neurol 46:139-142
8. Kinrys G, Vasconcelos e Sa D, Nery F (2007) Adjunctive zonisamide for treatment refractory anxiety. Int J Clin Pract 61:1050-1053
9. Murata M (2004) Novel therapeutic effects on the anticonvulsant, zonisamide on Parkinson's disease. Curr Pharm Des 10:687-693
10. Murata M, Hasegawa K, Kanazawa I (2006) Zonisamide improves motor function in Parkinson disease. A double-blind study. Neurology 68:45-50
11. Bermejo PE, Anciones B (2009) A review of the use of zonisamide in Parkinson's disease. Ther Adv Neurol Disord 2:313-317
12. Bermejo PE (2007) Zonisamide in patients with essential tremor and Parkinson's disease. Mov Disord 22:2137-2138
13. Mamikonyan E, Siderowf AD, Duda JE et al (2008) Long-term follow-up of impulse control disorders in Parkinson's disease. Mov Disord 23:75-80
14. Ardouin C, Voon V, Worbe Y et al (2006) Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Mov Disord 21:1941-1946
15. Driver-Dunckley E, Samanta J, Stacy M (2003) Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology 61:422-423
16. Voon V, Hassan K, Zurowski M et al (2006) Prospective prevalence of pathological gambling and medication association in Parkinson disease. Neurology 66:1750-1752
17. Jiménez-Jiménez FJ, Sayed Y, García-Soldevilla MA (2002) Possible zoophilia associated with dopaminergic therapy in Parkinson disease. Ann Pharmacother 36:1178-1179
18. Gschwandtner U, Aston J, Renaud S et al (2001) Pathologic gambling in patients with Parkinson's disease. Clin Neuropharmacol 24:170-172
19. Giovannoni G, O'Sullivan JD, Turner K et al (2000) Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68:423-428
20. Grant JE, Potenza MN, Hollander E et al (2006) Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry 163:303-312
21. Black KJ, Friedman JH (2006) Repetitive and impulsive behaviours in treated Parkinson disease. Neurology 67:1118-1119
22. Ceravolo R, Frosini D, Rossi C et al (2009) Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management. Parkinsonism Relat Disord 15:111-115
23. Schauf CL (1987) Zonisamide enhances slow sodium inactivation in Myxicola. Brain Res 413:185-188
24. Biton V (2007) Clinical pharmacology and mechanism of action of zonisamide. Clin Neuropharmacol 30:230-240
25. Kito M, Maehara M, Watanabe K (1996) Mechanisms of T-type calcium channel blockade by zonisamide. Seizure 5:115-119
26. Chen JT, Garcia PA, Alldredge BK (2003) Zonisamide-induced restless legs syndrome. Neurology 60:147
27. Bermejo PE, Zabala JA, Saez R (2007) Restless legs syndrome induced by zonisamide. Mov Disord 22:1517-1518
28. Knapp CM, Sarid-Segal O, Richardson MA et al (2010) Open label trial of the tolerability and efficacy of zonisamide in the treatment of alcohol dependence. Am J Drug Alcohol Abuse 36:102-105